Search Results - "Wan, Zesheng"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2

    Mechanism of Synergy of N-(4-Hydroxyphenyl)Retinamide and ABT-737 in Acute Lymphoblastic Leukemia Cell Lines: Mcl-1 Inactivation by Kang, Min H., Wan, Zesheng, Kang, Yun Hee, Sposto, Richard, Reynolds, C. Patrick

    “…Background ABT-737 is a pan-Bcl-2 inhibitor that has a wide range of single-agent activity against acute lymphoblastic leukemia (ALL) cell lines and…”
    Get full text
    Journal Article
  3. 3

    Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas by Darvishi, Emad, Slemmons, Katherine, Wan, Zesheng, Mitra, Sheetal, Hou, Xiaogang, Hugues Parmentier, Jean, Eddie Loh, Yong-Hwee, Helman, Lee J.

    Published in Neoplasia (New York, N.Y.) (01-07-2020)
    “…Fibroblast growth factor receptor 4 (FGFR4) aberrant expression and activity have been linked to the pathogenesis of a variety of cancers including…”
    Get full text
    Journal Article
  4. 4

    Histone Deacetylase 1 Gene Expression and Sensitization of Multidrug-Resistant Neuroblastoma Cell Lines to Cytotoxic Agents by Depsipeptide by Keshelava, Nino, Davicioni, Elai, Wan, Zesheng, Ji, Lingyun, Sposto, Richard, Triche, Timothy J., Reynolds, C. Patrick

    “…Background Genes that are overexpressed in multidrug-resistant neuroblastomas relative to drug-sensitive neuroblastomas may provide targets for modulating drug…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse Imaging by Liu, Hsiao-Chuan, Gang, Eun Ji, Kim, Hye Na, Ruan, Yongsheng, Ogana, Heather, Wan, Zesheng, Bönig, Halvard, Shung, K Kirk, Kim, Yong-Mi

    Published in Cells (Basel, Switzerland) (16-06-2020)
    “…Drug resistance is an obstacle in the therapy of acute lymphoblastic leukemia (ALL). Whether the physical properties such as the motility of the cells…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1 by Xu, Yibing, Sun, Jianping, Sheard, Michael A., Tran, Hung C., Wan, Zesheng, Liu, Wei Yao, Asgharzadeh, Shahab, Sposto, Richard, Wu, Hong Wei, Seeger, Robert C.

    Published in Cancer Immunology, Immunotherapy (01-10-2013)
    “…Background Treatment for children with high-risk neuroblastoma with anti-disialoganglioside mAb ch14.18, IL-2, and GM-CSF plus 13- cis -retinoic acid after…”
    Get full text
    Journal Article
  12. 12

    Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGF beta 1 by Xu, Yibing, Sun, Jianping, Sheard, Michael A, Tran, Hung C, Wan, Zesheng, Liu, Wei Yao, Asgharzadeh, Shahab, Sposto, Richard, Wu, Hong Wei, Seeger, Robert C

    Published in Cancer Immunology, Immunotherapy (01-10-2013)
    “…Background: Treatment for children with high-risk neuroblastoma with anti-disialoganglioside mAb ch14.18, IL-2, and GM-CSF plus 13-cis-retinoic acid after…”
    Get full text
    Journal Article
  13. 13

    Abstract 5920: Inhibition of TBL1 and β-catenin interaction sensitizes acute lymphoblastic leukemia to chemotherapy by Hurwitz, Samantha, Friedmann, Rachel, Fourfouris, Tatiana, Lee, Ki Jun, Wan, Zesheng, Parekh, Chintan, Navid, Fariba, Bhojwani, Deepa, Holloway, Kimberly, Kim, Yong-Mi

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…BACKGROUND: Relapse of T-cell acute lymphoblastic leukemia (T-ALL) and B-cell acute lymphoblastic leukemia (B-ALL) post-chemotherapy or post-immunotherapy…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGF[beta]1 by Xu, Yibing, Sun, Jianping, Sheard, Michael A, Tran, Hung C, Wan, Zesheng, Liu, Wei Yao, Asgharzadeh, Shahab, Sposto, Richard, Wu, Hong Wei, Seeger, Robert C

    Published in Cancer immunology, immunotherapy (01-10-2013)
    “…Treatment for children with high-risk neuroblastoma with anti-disialoganglioside mAb ch14.18, IL-2, and GM-CSF plus 13-cis-retinoic acid after myeloablative…”
    Get full text
    Journal Article
  18. 18

    Epithelial-Mesenchymal Interactions Are Linked to Neovascularization by Schwarz, Margaret A, Wan, ZeSheng, Liu, Jie, Lee, Matthew K

    “…Lung morphogenesis is dependent on interactions between mesenchymal and epithelial cells. We have previously demonstrated that inhibition of neovascularization…”
    Get full text
    Journal Article